41 results on '"Aupart, Michel"'
Search Results
2. Initial Study of the Extended STABILISE Technique for Complete Remodeling in Aortic Dissection
3. Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteria
4. Incidence, predictors, impact, and treatment of vascular complications after transcatheter aortic valve implantation in a modern prospective cohort under real conditions
5. Prosthesis Type for Aortic- and Mitral-Valve Replacement
6. Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves
7. Cardiovascular magnetic resonance in heart transplant patients: diagnostic value of quantitative tissue markers: T2 mapping and extracellular volume fraction, for acute rejection diagnosis
8. Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia
9. Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50–65 years†
10. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations
11. The INSPIRIS RESILIA Aortic Valve: From Bench to Bedside
12. STRUCTURAL VALVE DETERIORATION IN MITRAL REPLACEMENT SURGERY: COMPARISON OF CARPENTIER-EDWARDS SUPRA-ANNULAR PORCINE AND PERIMOUNT PERICARDIAL BIOPROSTHESES
13. Aortic treatment of native infection by reconstruction with the Omniflow II biologic prosthesis
14. Bioprosthetic mitral valve replacement in patients aged 65 years or younger: long-term outcomes with the Carpentier–Edwards PERIMOUNT pericardial valve†
15. Heart transplantation in selected patients aged 60 years and older: a two-decade retrospective and multicentre analysis
16. 0408 : Stimulation of P2Y11 purinergic receptor reduces rejection lesions and increases survival time of heart allograft in a mouse model
17. Cardiac Magnetic Resonance in heart transplant patients: diagnostic value of quantitative tissue markers (T2 mapping and ECV) for acute cardiac rejection diagnosis
18. Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50–65 years
19. Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger
20. Tolerance of Rapid Right Ventricular Pacing during Thoracic Endovascular Aortic Repair
21. Very Long-Term Outcomes of the Carpentier-Edwards Perimount Valve in Aortic Position
22. C0343 Polymorphisms of protein tyrosine phosphatase CD148 influence Fcgammariia-dependent platelet activation and the risk of heparin-induced thrombocytopenia
23. A 25-year experience with Carpentier-Edwards Perimount in the mitral position
24. Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome
25. 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses
26. High Efficiency Activation of L-Type Ca2+Current by 5-HT in Human Atrial Myocytes
27. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis
28. Inhibitory Activity of Antibodies Against the Human Atrial 5-HT4Receptor
29. Structural valve deterioration in mitral replacement surgery: Comparison of carpentier-edwards supra-annular porcine and perimount pericardial bioprostheses
30. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience
31. Leiomyosarcoma of the pulmonary artery
32. Severe and Early Alteration of Action Potential During Acute Cardiac Rejection in Rats
33. The last generation of pericardial valves in the aortic position: Ten-year follow-up in 589 patients
34. Electrocardiographic and Electrophysiologic Properties of Cardiac Allografts
35. New procedure to replace the aortic valve with autologous pericardium: A clinical case
36. Consequences of heterotopic heart transplantation on the native heart
37. High Efficiency Activation of L-Type Ca 2+ Current by 5-HT in Human Atrial Myocytes.
38. Polymorphisms of protein tyrosine phosphatase CD 148 influence Fc&ggr;RIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.
39. Risk factors for valve-related complications after mechanical heart valve replacement in 505 patients with long-term follow up.
40. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients.
41. High efficiency activation of L-type Ca2+ current by 5-HT in human atrial myocytes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.